Low serum level is associated with lypodistrophy, insulin resistance and dyslipidemia (248). ART reduces the level of adiponectin and its effect is more significant in patients with hypertriglyceridemia (247, 251). Adiponectin supplementation may improve ART-induced metabolic changes (210, 212). The gene discussed is ADIPOQ; the disease is metabolic syndrome.